Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells.
Zwaveling S, Vierboom MP, Ferreira Mota SC, Hendriks JA, Ooms ME, Sutmuller RP, Franken KL, Nijman HW, Ossendorp F, Van Der Burg SH, Offringa R, Melief CJ.
Zwaveling S, et al.
Cancer Res. 2002 Nov 1;62(21):6187-93.
Cancer Res. 2002.
PMID: 12414646